Researchers have substantially improved this development of an new solution for ATTR-CM, leveraging the compound. Initial trial data suggests promising improvements for those affected by the serious disease. The focus https://bridgebio246411.timeblog.net/78040216/bridgebio-advances-attr-cm-treatment-through-attruby